Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-trimoxazole in idiopathic interstitial pneumonia
2007-002324-15Phase 4Completed
- Sponsor
- University of East Anglia
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in idiopathic interstitial pneumonia (IIP), idiopathic pulmonary fibrosis (IPF) and interstitial lung disease (ILD) comparing Co-trimoxazole + standard care with Placebo + standard care (2 arms). Primary endpoint: Change in forced vital capacity. Started Mar 2008; status: completed.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
idiopathic interstitial pneumonia (IIP)idiopathic pulmonary fibrosis (IPF)interstitial lung disease (ILD)
Beyond the preview
Go deeper on 2007-002324-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002324-15.